Normal and leukemic human stem cells assayed in SCID mice.
about
Mammary stem cells, self-renewal pathways, and carcinogenesisC1qRp defines a new human stem cell population with hematopoietic and hepatic potentialIdentification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapyAbsence of CD34 on some human SCID-repopulating cells.Biological consequences of the BCR/ABL fusion gene in humans and miceCellular and molecular aspects of human CD34+ CD38- precursors: analysis of a primitive hematopoietic population.In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory.Normal and leukemic CD34-negative human hematopoietic stem cells.Preferential induction of apoptosis for primary human leukemic stem cells.Recent translational research: stem cells as the roots of breast cancerHaematopoietic stem cells.Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity.Animal models of acute myelogenous leukaemia - development, application and future perspectives.Normal and leukaemic stem cells.Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells.Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture.NF-kappa B-mediated adaptive resistance to ionizing radiation.Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid micePurification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.Cancer, stem cells, and oncolytic viruses.Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells.MicroRNA regulation of cancer stem cells and therapeutic implications.Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention.Recent updates on the role of microRNAs in prostate cancer.Contribution of GATA1 dysfunction to multi-step leukemogenesis.Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.Expansion of human SCID-repopulating cells under hypoxic conditions.Hematopoietic Growth Factors and Blast Progenitors in Acute Leukemia.Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells.Isolation and therapeutic potential of human haemopoietic stem cells.Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors.Distinct classes of human stem cells that differ in proliferative and self-renewal potential.Evaluation of ex vivo expansion and engraftment in NOD-SCID mice of umbilical cord blood CD34+ cells using the DIDECO "Pluricell System".Pituitary adenomas, stem cells, and cancer stem cells: what's new?Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells.CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia
P2860
Q24529145-5DB7C611-CBCA-4863-90E0-E376C95F1B5CQ24533499-8D134BB0-A716-4071-BDAF-7273C5D812C4Q28298655-92A057AE-39A9-448A-8EDE-5F50E9D02EEFQ33661881-7BE03F71-1D81-43E3-BF15-DBA48CF3448AQ33837337-0D4A531D-5F59-4C7C-8DF2-043ED5688BA2Q34011542-19781B83-C36F-4AB1-8212-0B8F2E720911Q34034653-88A55EE2-6C7C-4F31-A234-0695B174DF56Q34235845-085717D4-D714-46A5-8F48-381BC9A3E07AQ34326880-1F39D66B-15E6-4C14-AFD2-64B3F690B920Q34415832-9971A044-ACD2-43BF-BB76-1161E1286FAFQ34480692-9FF06845-182E-4AD9-B381-29897A25CE41Q34736824-6B3610AC-2DD5-4325-944E-33F54C6962F7Q35596820-3BC8BA87-086B-45F8-A1B4-B33F89624490Q36066980-D3C8843A-D511-4B47-A7A4-6F7385EECCA7Q36228053-8DCC6FF0-A3FD-4D8F-B8F5-AAA4A220B35CQ36368023-701FABAB-3DA8-4DBE-81D1-8AD625907FC5Q36380522-44CD9178-B810-436E-AC47-0906173D9ECDQ36493029-051815A9-32E7-4580-8BBC-B5281F94FBEEQ36576511-0AF9C3CC-1D19-4EDB-8F1F-42A52A5B168EQ36621599-3A265529-CB34-4106-BC6A-5B151ABDD6B4Q36772601-2AAD1C94-777A-4434-929B-AAFBA7EE7EBBQ37209758-FDB3A90B-367D-49D4-8C6F-5A096FA43CA1Q37420601-949C7154-429E-43DD-BAAA-49844D2F449DQ37618041-42145EAA-5D7C-4D0A-AC43-BDDC1600E2B5Q37661508-68525919-CED3-49EB-952A-762D829A3F83Q37993624-04DA91E0-A4A9-4EF2-8BA3-FD18D8E3BAC2Q38039448-978E6A10-407F-48C6-9EAC-4E39BB392EE9Q39752820-C087271F-8E4D-40D5-A0BE-71512D29C162Q39778145-2C597CE1-AC14-4AB9-818E-B3C5BAD51E49Q40907374-5A451B7E-A253-41B1-A5F2-7D2AD6D56DE4Q41653162-53F7E8DC-2876-46C4-B735-368A7956FFDDQ41787137-6BC3156B-7A18-4A7C-9AF9-77B8F07B2ED8Q45855831-65BE4E93-3814-4E0D-9E21-DD91CC33132EQ45873643-9B391F92-76BE-4FC9-B899-1ECD418317C5Q46430954-014A4280-CD37-4F91-93DD-6641C74C2B12Q49986979-628B3D54-486E-4562-A11C-A9083C2AECC0Q54546054-1A0EA0A1-B0D6-45B4-8D9C-F0CE04BC0070Q55057708-1B127806-795A-471D-B21C-649774EE3D96Q58237073-84EE4E7E-7E5B-462A-A025-4D2682A552AB
P2860
Normal and leukemic human stem cells assayed in SCID mice.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Normal and leukemic human stem cells assayed in SCID mice.
@en
type
label
Normal and leukemic human stem cells assayed in SCID mice.
@en
prefLabel
Normal and leukemic human stem cells assayed in SCID mice.
@en
P356
P1476
Normal and leukemic human stem cells assayed in SCID mice
@en
P2093
P304
P356
10.1006/SMIM.1996.0025
P50
P577
1996-08-01T00:00:00Z